Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > The manipulators are pulling their asks-----

<< Previous

Bullboard Posts

Next >>

Comment by skys1on Sep 15, 2022 12:46pm

322 Views

Post# 34964721

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:The manipulators are pulling their asks-----

Yes Legit a PP would be "material" because it would probably effect share price, therefore according to the NASDAQ rules would have to be reported "PROMPTLY". I strongly suspect Toronto has the same requirements. If TLT had a PP, it would have had to be reported.

<< Previous

Bullboard Posts

Next >>

Sony’s Alpha 1 II: A new professional photography standard?